Literature DB >> 2995270

Biology of rat cytomegalovirus infection.

C A Bruggeman, H Meijer, F Bosman, C P van Boven.   

Abstract

Cytomegalovirus infection of Brown Norway rats was studied after intraperitoneal or subcutaneous inoculation of virus. No clinical illness was apparent during the 1st month postinfection (p.i.). Low titers of virus were detected in many organs at day 4 p.i. for the intraperitoneally inoculated animals and at day 11 p.i. for those inoculated subcutaneously. Thereafter, the virus disappeared from all tested organs except the salivary glands, where it appeared on day 11 p.i. and reached high levels by 4 weeks p.i. Histologically, no abnormalities were observed. The virus had an immunosuppressive effect during the 1st week p.i., as indicated by the immune response to sheep red blood cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995270     DOI: 10.1159/000149612

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  27 in total

1.  Induction of vascular adhesion protein-1 during liver allograft rejection and concomitant cytomegalovirus infection in rats.

Authors:  T Martelius; M Salmi; H Wu; C Bruggeman; K Höckerstedt; S Jalkanen; I Lautenschlager
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Treatment of experimental cytomegalovirus infections with acyclovir.

Authors:  C A Bruggeman; W Engels; J Endert
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Rat cytomegalovirus gene expression in cardiac allograft recipients is tissue specific and does not parallel the profiles detected in vitro.

Authors:  Daniel N Streblow; Koen W R van Cleef; Craig N Kreklywich; Christine Meyer; Patricia Smith; Victor Defilippis; Finn Grey; Klaus Früh; Robert Searles; Cathrien Bruggeman; Cornelis Vink; Jay A Nelson; Susan L Orloff
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

4.  The development and characterization of monoclonal antibodies against rat cytomegalovirus induced antigens.

Authors:  J H Bruning; W H Debie; P H Dormans; H Meijer; C A Bruggeman
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

5.  Impaired arterial reactivity following cytomegalovirus infection in the immunosuppressed rat.

Authors:  P H Eerdmans; M C Persoons; S J Debets; H A Struijker Boudier; J F Smits; C A Bruggeman; J G De Mey
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

Review 6.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

7.  Suppression of humoral antibody formation against sheep red blood cells by infections with HSV-2 and the influence of mouse cytomegalovirus. Brief report.

Authors:  S Nick; B Metzger; S Jonsić; D Falke
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

8.  Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo.

Authors:  F S Stals; E de Clercq; C A Bruggeman
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

9.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

10.  Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.

Authors:  K B Lemström; J H Bruning; C A Bruggeman; I T Lautenschlager; P J Häyry
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.